[1] |
ENTMACHER PS, MARKS HH. Diabetes in 1964; a world survey[J]. Diabetes, 1965, 14: 212-223. DOI: 10.2337/diab.14.4.212.
|
[2] |
SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2019, 157: 107843. DOI: 10.1016/j.diabres.2019.107843.
|
[3] |
PATTERSON CC, KARURANGA S, SALPEA P, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2019, 157: 107842. DOI: 10.1016/j.diabres.2019.107842.
|
[4] |
NOGUCHI H, KITADA H, KAKU K, et al. Outcome of renal transplantation in patients with type 2 diabetic nephropathy: a single-center experience[J]. Transplant Proc, 2015, 47(3): 608-611. DOI: 10.1016/j.transproceed.2014.12.047.
|
[5] |
ESMEIJER K, HOOGEVEEN EK, VAN DEN BOOG PJM, et al. Superior long-term survival for simultaneous pancreas-kidney transplantation as renal replacement therapy: 30-year follow-up of a nationwide cohort[J]. Diabetes Care, 2020, 43(2): 321-328. DOI: 10.2337/dc19-1580.
|
[6] |
CHAN CM, CHIM TM, LEUNG KC, et al. Simultaneous pancreas and kidney transplantation as the standard surgical treatment for diabetes mellitus patients with end-stage renal disease[J]. Hong Kong Med J, 2016, 22(1): 62-69. DOI: 10.12809/hkmj154613.
|
[7] |
POMPOSELLI T, SCHUETZ C, WANG P, et al. A strategy to simultaneously cure type 1 diabetes and diabetic nephropathy by transplant of composite islet-kidney grafts[J]. Front Endocrinol (Lausanne), 2021, 12: 632605. DOI: 10.3389/fendo.2021.632605.
|
[8] |
COOPER DKC, GASTON R, ECKHOFF D, et al. Xenotransplantation-the current status and prospects[J]. Br Med Bull, 2018, 125(1): 5-14. DOI: 10.1093/bmb/ldx043.
|
[9] |
BERTERA S, KNOLL MF, KNOLL CA, et al. Pig-to-macaque islet xenotransplantation[J]. Methods Mol Biol, 2020, 2110: 289-314. DOI: 10.1007/978-1-0716-0255-3_19.
|
[10] |
GAMBLE A, PEPPER AR, BRUNI A, et al. The journey of islet cell transplantation and future development[J]. Islets, 2018, 10(2): 80-94. DOI: 10.1080/19382014.2018.1428511.
|
[11] |
STOKES RA, CHENG K, LALWANI A, et al. Transplantation sites for human and murine islets[J]. Diabetologia, 2017, 60(10): 1961-1971. DOI: 10.1007/s00125-017-4362-8.
|
[12] |
尹注增, 刘荣. 胰岛移植部位的选择及优缺点[J/CD]. 实用器官移植电子杂志, 2016, 4(6): 355-359. DOI: 10.3969/j.issn.2095-5332.2016.06.007.YIN ZZ, LIU R. Selection and advantages and disadvantages of islet transplantation site[J/CD]. Pract J Organ Transplant (Electr Vers), 2016, 4(6): 355-359. DOI: 10.3969/j.issn.2095-5332.2016.06.007.
|
[13] |
ADDISON P, FATAKHOVA K, RODRIGUEZ RILO HL. Considerations for an alternative site of islet cell transplantation[J]. J Diabetes Sci Technol, 2020, 14(2): 338-344. DOI: 10.1177/1932296819868495.
|
[14] |
SHRESTHA P, BATRA L, TARIQ MALIK M, et al. Immune checkpoint CD47 molecule engineered islets mitigate instant blood-mediated inflammatory reaction and show improved engraftment following intraportal transplantation[J]. Am J Transplant, 2020, 20(10): 2703-2714. DOI: 10.1111/ajt.15958.
|
[15] |
DELAUNE V, BERNEY T, LACOTTE S, et al. Intraportal islet transplantation: the impact of the liver microenvironment[J]. Transpl Int, 2017, 30(3): 227-238. DOI: 10.1111/tri.12919.
|
[16] |
LI X, MENG Q, ZHANG L. The fate of allogeneic pancreatic islets following intraportal transplantation: challenges and solutions[J]. J Immunol Res, 2018: 2424586. DOI: 10.1155/2018/2424586.
|
[17] |
HENRIKSNÄS J, LAU J, ZANG G, et al. Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization[J]. Diabetes, 2012, 61(3): 665-673. DOI: 10.2337/db10-0895.
|
[18] |
MOLNÁR C, ESSAND M, WENNBERG L, et al. Islet engraftment and revascularization in clinical and experimental transplantation[J]. Cell Transplant, 2013, 22(2): 243-251. DOI: 10.3727/096368912X640637.
|
[19] |
SHAPIRO AM, RICORDI C, HERING BJ, et al. International trial of the Edmonton protocol for islet transplantation[J]. N Engl J Med, 2006, 355(13): 1318-1330. DOI: 10.1056/NEJMoa061267.
|
[20] |
STOKES RA, SIMOND DM, BURNS H, et al. Transplantation sites for porcine islets[J]. Diabetologia, 2017, 60(10): 1972-1976. DOI: 10.1007/s00125-017-4363-7.
|
[21] |
SMOOD B, BOTTINO R, HARA H, et al. Is the renal subcapsular space the preferred site for clinical porcine islet xenotransplantation? review article[J]. Int J Surg, 2019, 69: 100-107. DOI: 10.1016/j.ijsu.2019.07.032.
|
[22] |
KEMTER E, WOLF E. Recent progress in porcine islet isolation, culture and engraftment strategies for xenotransplantation[J]. Curr Opin Organ Transplant, 2018, 23(6): 633-641. DOI: 10.1097/MOT.0000000000000579.
|
[23] |
NAGARAJU S, BOTTINO R, WIJKSTROM M, et al. Islet xenotransplantation: what is the optimal age of the islet-source pig?[J]. Xenotransplantation, 2015, 22(1): 7-19. DOI: 10.1111/xen.12130.
|
[24] |
VANDERSCHELDEN R, SATHIALINGAM M, ALEXANDER M, et al. Cost and scalability analysis of porcine islet isolation for islet transplantation: comparison of juvenile, neonatal and adult pigs[J]. Cell Transplant, 2019, 28(7): 967-972. DOI: 10.1177/0963689719847460.
|
[25] |
HE S, WANG C, DU X, et al. MSCs promote the development and improve the function of neonatal porcine islet grafts[J]. FASEB J, 2018, 32(6): 3242-3253. DOI: 10.1096/fj.201700991R.
|
[26] |
KIM S, WHITENER RL, PEIRIS H, et al. Molecular and genetic regulation of pig pancreatic islet cell development[J]. Development, 2020, 147(6): dev186213. DOI: 10.1242/dev.186213.
|
[27] |
SMITH KE, PURVIS WG, DAVIS MA, et al. In vitro characterization of neonatal, juvenile, and adult porcine islet oxygen demand, β-cell function, and transcriptomes[J]. Xenotransplantation, 2018, 25(6): e12432. DOI: 10.1111/xen.12432.
|